flow trial semaglutide nejm ✍️✓🆕A pathbreaking published in @NEJM today 👍FLOW Trial 💉in Diabetic CKD 🫡Significant benefits in renal and cardiovascular outcomes @ERAkidney #ERA24 @NEJM Semaglutide in CKD - The

Insulin resistance Around 65 to 70% of people with PCOS have insulin resistance, which increases fat storage, making it more difficult to break down fat and control blood sugar levels

Sleeve gastrectomy activates the GLP-1 pathway in pancreatic cells and promotes GLP-1-expressing cells differentiation in the intestinal tract

The verdict Conditional on most plans Blue Shield of California restricts new Wegovy weight-loss starts to BMI 40 or higher (Class III/morbid obesity) since January 1, 2025 meaning patients at BMI 3039 who otherwise qualify under the FDA label are excluded from new weight-loss coverage

They also check for creatine kinase

For metabolic studies, blood was taken via the tail vein into heparin-coated capillary tubes